- Home
- Industry Reports
- Healthcare
- Pharmaceuticals
- Global Anticoccidial Drugs Market – Industry Analysis, Growth, Size, Outlook, Trends and Forecast (2024 – 2032)
Coccidiasina is microscopic, single-cell, spore-forming parasite that can infect all mammals. Infection with these parasites is known as Coccidiosis. Most species of coccidia are species-specific, i.e. they choose their host to reproduce and infect. Fever, vomiting, diarrhoea, nervous system effects and change in behaviour are some symptoms. These parasites infect the intestine tracts of the host.
Global Anticoccidial Drugs Market Share:
The Global Anticoccidial drugs market share might grow up to USD 29.62 billion by the year 2024.
Global Anticoccidial Drugs Market Size:
The global anticoccidial drugs market is segmented into numerous types of animals and by class of drugs. The animal segment is further sub-divided into swine, poultry, cattle, fish, and companion animals such as cats, dogs, and ruminants. The drug segment comprises Ionophoreanticoccidials, antibiotic anticoccidials, amprolium derivatives, sulphonamides derivatives, ethopabate derivatives, clopidol derivatives, quinolones derivatives and other derivatives anticoccidials drugs.
Global Anticoccidial Market Growth:
Regarding geographic segmentation, North America rules the global anticoccidial drugs market due to the prophylactic usage of anticoccidials in animal feed. The U.S. reflects the humongous demand for anticoccidial drugs usage followed by Canada and Mexico in North America. Growing meat consumption in the region primarily drives the European market for the anticoccidial drug. Germany, France, the U.K., and Spain holds a prime share of the European anticoccidial drugs market. Nonetheless, Asia is expected to project high growth rates in the next six years in the global anticoccidial drug market. This is mainly due to the ever-growing demand for meat proteins in countries like India and China.
Global Anticoccidial Drugs Market Industry Analysis:
The trends of owning companion animals are growing in both developed and developing regions, which reflect the growth of the anticoccidial drugs market. There are other factors which have driven the market, like increasing incidences of the disease coccidiosis, the high demand for meat proteins, which led to the demand for meat.
Global Anticoccidial Drugs Market Outlook:
Reduced stringent regulations and surged government spending on animals like dogs, cats, and ruminants are also aiding in the growth of global anticoccidial drugs market. In extension, food safety concerns and increasing meat prices in various parts of the world holds enormous potential for the growth of the global anticoccidial drugs market.
Global Anticoccidial Market Trends:
Zoetis announce that it will be receiving a US$ 14.4 million grant from the Bill & Melinda Foundation over the next three years to develop veterinary diagnostic networks and animal health infrastructure in Ethiopia, Nigeria, and Uganda.
Global Anticoccidial Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions.
- Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact on altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
-
- Zoetis
- Elanco
- Merial
- Bayer Healthcare Animal Healthcare Division
- Merck Animal Healthcare
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Drug Type
6.1 Antibiotic Derivatives
6.2 Ionophore Derivatives
6.3 Amprolium Derivatives
6.4 Sulphonamides Derivatives
6.4 Ethopabate Derivatives
6.5 Clopidol Derivatives
6.6 Quinolones Derivatives
6.7 Other Derivatives
Chapter 7Market Segmentation by Animal Type
7.1 Poultry
7.2 Swine
7.3 Fish
7.4 Cattle
7.5 Companion Animals
7.5.1 Dogs
7.5.2 Cats
7.5.3 Ruminants
7.6 Others
Chapter 8 Market Segmentation by Geography
8.1 Asia Pacific
8.1.1 Introduction
8.1.2 China
8.1.3 India
8.1.4 Japan
8.1.5 Australia
8.1.6 Others
8.2 North America
8.2.1 Introduction
8.2.2 United States
8.2.3 Canada
8.2.4 Mexico
8.2.5 Others
8.3 Europe
8.3.1 Introduction
8.3.2 Spain
8.3.3 UK
8.3.4 France
8.3.5 Russia
8.3.6 Italy
8.3.7 Others
8.4 the Middle East and Africa
8.4.1 Introduction
8.4.2 South Africa
8.4.3 Middle East Countries
8.4.4 Others
8.5 South America
8.5.1 Introduction
8.5.2 Argentina
8.5.3 Brazil
8.5.5 Others
Chapter 9 Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted By Top Companies
Chapter 10 Company Profiles
10.1 Zoetis
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiative
11.2 Elanco (A Division of Eli Lilly and Company)
11.3 Merial
11.4 Bayer Healthcare Animal Healthcare Division
11.5 Merck Animal Healthcare
11.6 Boehringer Ingelheim Animal Health
11.7 Huvepharma
11.8Virbac
11.9Ceva Santé Animal Healthcare
11.10 Novartis Animal Healthcare
11.11Smartvec Inc.
11.12 Intas
11.13 Dosch Pharmaceuticals
11.14 Jurox
11.15 Biopredic
Chapter 11 Market Estimates and Forecast
11.1 Market Estimates and Forecast 2018-2024(USD Million)
11.1.1 Market Estimation and Forecast by Drug Type 2018-2024(USD Million)
11.1.2 Market Estimates and Forecast by Animal Type 2018-2024(USD Million)
11.1.3 Market Estimates and Forecast by Geography 2018-2024(USD Million)
11.1.4 Market Estimates and Forecast by Company 2018-2024(USD Million)
Chapter 12 Market Insights
12.1 Insights of Industry Experts
12.2 Analyst Opinion (Market Understanding)
12.3 Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,484.82 - €7,454.45
- INR: ₹225,447.27 - ₹676,341.80
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,133.21 - £6,399.64
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Coccidiasina is microscopic, single-cell, spore-forming parasite that can infect all mammals. Infection with these parasites is known as Coccidiosis. Most species of coccidia are species-specific, i.e. they choose their host to reproduce and infect. Fever, vomiting, diarrhoea, nervous system effects and change in behaviour are some symptoms. These parasites infect the intestine tracts of the host.
Global Anticoccidial Drugs Market Share:
The Global Anticoccidial drugs market share might grow up to USD 29.62 billion by the year 2024.
Global Anticoccidial Drugs Market Size:
The global anticoccidial drugs market is segmented into numerous types of animals and by class of drugs. The animal segment is further sub-divided into swine, poultry, cattle, fish, and companion animals such as cats, dogs, and ruminants. The drug segment comprises Ionophoreanticoccidials, antibiotic anticoccidials, amprolium derivatives, sulphonamides derivatives, ethopabate derivatives, clopidol derivatives, quinolones derivatives and other derivatives anticoccidials drugs.
Global Anticoccidial Market Growth:
Regarding geographic segmentation, North America rules the global anticoccidial drugs market due to the prophylactic usage of anticoccidials in animal feed. The U.S. reflects the humongous demand for anticoccidial drugs usage followed by Canada and Mexico in North America. Growing meat consumption in the region primarily drives the European market for the anticoccidial drug. Germany, France, the U.K., and Spain holds a prime share of the European anticoccidial drugs market. Nonetheless, Asia is expected to project high growth rates in the next six years in the global anticoccidial drug market. This is mainly due to the ever-growing demand for meat proteins in countries like India and China.
Global Anticoccidial Drugs Market Industry Analysis:
The trends of owning companion animals are growing in both developed and developing regions, which reflect the growth of the anticoccidial drugs market. There are other factors which have driven the market, like increasing incidences of the disease coccidiosis, the high demand for meat proteins, which led to the demand for meat.
Global Anticoccidial Drugs Market Outlook:
Reduced stringent regulations and surged government spending on animals like dogs, cats, and ruminants are also aiding in the growth of global anticoccidial drugs market. In extension, food safety concerns and increasing meat prices in various parts of the world holds enormous potential for the growth of the global anticoccidial drugs market.
Global Anticoccidial Market Trends:
Zoetis announce that it will be receiving a US$ 14.4 million grant from the Bill & Melinda Foundation over the next three years to develop veterinary diagnostic networks and animal health infrastructure in Ethiopia, Nigeria, and Uganda.
Global Anticoccidial Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions.
- Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact on altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
-
- Zoetis
- Elanco
- Merial
- Bayer Healthcare Animal Healthcare Division
- Merck Animal Healthcare
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Drug Type
6.1 Antibiotic Derivatives
6.2 Ionophore Derivatives
6.3 Amprolium Derivatives
6.4 Sulphonamides Derivatives
6.4 Ethopabate Derivatives
6.5 Clopidol Derivatives
6.6 Quinolones Derivatives
6.7 Other Derivatives
Chapter 7Market Segmentation by Animal Type
7.1 Poultry
7.2 Swine
7.3 Fish
7.4 Cattle
7.5 Companion Animals
7.5.1 Dogs
7.5.2 Cats
7.5.3 Ruminants
7.6 Others
Chapter 8 Market Segmentation by Geography
8.1 Asia Pacific
8.1.1 Introduction
8.1.2 China
8.1.3 India
8.1.4 Japan
8.1.5 Australia
8.1.6 Others
8.2 North America
8.2.1 Introduction
8.2.2 United States
8.2.3 Canada
8.2.4 Mexico
8.2.5 Others
8.3 Europe
8.3.1 Introduction
8.3.2 Spain
8.3.3 UK
8.3.4 France
8.3.5 Russia
8.3.6 Italy
8.3.7 Others
8.4 the Middle East and Africa
8.4.1 Introduction
8.4.2 South Africa
8.4.3 Middle East Countries
8.4.4 Others
8.5 South America
8.5.1 Introduction
8.5.2 Argentina
8.5.3 Brazil
8.5.5 Others
Chapter 9 Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted By Top Companies
Chapter 10 Company Profiles
10.1 Zoetis
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiative
11.2 Elanco (A Division of Eli Lilly and Company)
11.3 Merial
11.4 Bayer Healthcare Animal Healthcare Division
11.5 Merck Animal Healthcare
11.6 Boehringer Ingelheim Animal Health
11.7 Huvepharma
11.8Virbac
11.9Ceva Santé Animal Healthcare
11.10 Novartis Animal Healthcare
11.11Smartvec Inc.
11.12 Intas
11.13 Dosch Pharmaceuticals
11.14 Jurox
11.15 Biopredic
Chapter 11 Market Estimates and Forecast
11.1 Market Estimates and Forecast 2018-2024(USD Million)
11.1.1 Market Estimation and Forecast by Drug Type 2018-2024(USD Million)
11.1.2 Market Estimates and Forecast by Animal Type 2018-2024(USD Million)
11.1.3 Market Estimates and Forecast by Geography 2018-2024(USD Million)
11.1.4 Market Estimates and Forecast by Company 2018-2024(USD Million)
Chapter 12 Market Insights
12.1 Insights of Industry Experts
12.2 Analyst Opinion (Market Understanding)
12.3 Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.